Thrivent Financial for Lutherans Buys 1,314,177 Shares of Tema Oncology ETF $CANC

Thrivent Financial for Lutherans boosted its stake in Tema Oncology ETF (NASDAQ:CANC) by 891.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,461,649 shares of the company’s stock after acquiring an additional 1,314,177 shares during the period. Thrivent Financial for Lutherans owned 36.63% of Tema Oncology ETF worth $50,747,000 at the end of the most recent reporting period.

Separately, Jane Street Group LLC boosted its holdings in Tema Oncology ETF by 59.7% in the second quarter. Jane Street Group LLC now owns 14,104 shares of the company’s stock valued at $349,000 after acquiring an additional 5,275 shares in the last quarter.

Tema Oncology ETF Stock Down 2.3%

NASDAQ:CANC opened at $37.09 on Friday. The stock has a market cap of $173.95 million, a P/E ratio of 20.39 and a beta of 0.74. The firm’s fifty day simple moving average is $37.22 and its 200 day simple moving average is $35.85. Tema Oncology ETF has a twelve month low of $22.78 and a twelve month high of $39.95.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.